- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00200720
Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health
Metabolic Consequences of High and Low Carbohydrate Diets
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The number of overweight and obese Americans has increased significantly in recent years. There are now many different diet plans being promoted by doctors and the media. The Atkins diet, a low carbohydrate nutritional plan, is especially popular; its advocates claim that following the diet will result in long-term weight loss with no negative effects. Another diet, called the Dietary Approaches to Stop Hypertension (DASH) diet, is a high carbohydrate diet designed to help treat and prevent high blood pressure. However, more thorough investigation of these claims is needed. This study will compare the short- and long-term effects of the Atkins diet to the (DASH) diet. This trial will enroll overweight and obese participants.
This study will last 30 months and will comprise two phases. Participants will be randomly assigned to either the Atkins or DASH diet for 30 months. During Phase 1, all participants will undergo 6 months of weekly group therapy to encourage weight loss. Phase 2 is a weight loss maintenance phase. During Phase 2, participants will have monthly meetings with a therapist for weight loss support. Study visits will occur at study entry and at Months 3 and 30. At each study visit, weight measurements, blood and urine collection, and x-rays will occur to determine participants' weight loss, cardiovascular health, kidney function, and bone density.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Kaiser Permanente Center for Health Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body mass index (BMI) of 27 to 50
- Fasting glucose less than 126 mg/dl
- Total fasting cholesterol less than 260 mg/dl
- Total fasting triglycerides less than 400 mg/dl
- Permission of primary care provider to participate in the study
- Normal liver and kidney function
- Willing to modify diet and other health behaviors
- Willing to use an acceptable method of contraception for the duration of the study
Exclusion Criteria:
- Any medical condition that may make weight loss medically inadvisable
- Weigh more than 400 lbs
- History of kidney failure
- Current use of more than 3 blood pressure medications
- Change in blood pressure medications within 3 months prior to study entry
- Diagnosis of cardiovascular disease within 6 months prior to study entry
- Cancer diagnosis within 2 years of study entry. Participants with basal cell skin cancer are not excluded.
- History of psychiatric hospitalization within 2 years prior to study entry
- Consumption of more than three alcoholic drinks a day
- Type I or II diabetes
- Current use of hypolipidemics, antipsychotics, hypoglycemics, glucocorticoids, or thyroid medication
- Plan to move during study
- Current participation in another clinical trial
- Pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Atkins Diet
Participants randomized to this arm will consume a low carbohydrate diet as described by Dr. Robert Atkins in his book: Dr. Atkins' New Diet Revolution New York: Avon Books, 2002.
|
|
|
Active Comparator: DASH Diet
Participants randomized to this arm will consume the Dietary Approaches to Stop Hypertension (DASH) diet as described here: http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight loss
Time Frame: monthly
|
Excess weight loss (greater than 5 pounds a week)would trigger patient assessment.
|
monthly
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk of cardiovascular disease
Time Frame: Every six months
|
Elevated lipids or rising blood pressure during six month safety assessments would trigger additional participant evaluation
|
Every six months
|
|
bone health
Time Frame: end of study
|
end of study
|
|
|
kidney function
Time Frame: every six months
|
every six months
|
|
|
neuroendocrine mechanisms of hunger and satiety
Time Frame: end of study
|
end of study
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Njeri Karanja, PhD, Kaiser Permanente
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21AT000525-01 (U.S. NIH Grant/Contract)
- 1R01AT001930 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Atkins diet (low carbohydrate diet)
-
Boston Medical CenterRobert C. Atkins FoundationCompletedObesity | Cardiovascular HealthUnited States
-
University Health Network, TorontoUnknown
-
National Center for Complementary and Integrative...Community Foundation of Southeastern MichiganCompleted
-
Temple UniversityNational Institutes of Health (NIH); National Center for Complementary and...Completed
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Oregon Health and Science UniversityKaiser PermanenteCompletedObesity
-
Uppsala UniversityCompleted
-
University of SurreyBritish Heart FoundationCompleted
-
Brigham and Women's HospitalBoston Children's Hospital; Boston Medical Center; Nutrition Science Initiative; New Balance Foundation and other collaboratorsCompleted
-
University Hospital, MotolCzech Academy of SciencesActive, not recruiting